Ian McDonald
Chief Executive Officer, Director
Our Approach
Based on a proprietary chemistry platform Bright Minds have developed highly selective 5-HT2A and 5-HT2C agonists without 5-HT2B activity.
Our Science
Our Team
Chief Executive Officer, Director
Director, Chief Science Officer
Chief Medical Officer
Chief Financial Officer
Vice President of Pharmacology
Senior Advisor
Senior Advisor
Advisor
Toxicology Advisor
Senior Advisor
Advisor
Senior Advisor
Chief Operating Officer, VP Corporate Development
"*" indicates required fields